clinical trial · NCT07089576
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
Artivion Inc.·N/A·recruiting·n = 132
Aortic Arch AneurysmAortic Arch DissectionChronic Aortic DissectionAcute Aortic DissectionArcevo™ LSA Hybrid Stent Graft System
brief summary
The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.
started
Nov 4, 2025
primary completion
Apr 1, 2028
completion
Jul 1, 2032
last updated
Apr 21, 2026
official title
A Prospective, Multi-center Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA in the Open Repair of Aortic Arch Aneurysms and Dissections
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol